Chinese artificial intelligence (AI)-based microbiome drug developer Xbiome has completed a new funding round led by the country’s venture capital firm Gaorong Capital and a Shenzhen-based investment company, according to a statement released on Monday. The new investment is composed of two tranches of capital injections including a series A round raised in August 2018 […]

Gaorong Capital Leads New Round In Chinese AI-Based Microbiome Drug Developer comes originally from China Money Network. All Rights Reserved.